| scholarly article | Q13442814 |
| P356 | DOI | 10.4088/JCP.V67N1106 |
| P698 | PubMed publication ID | 17196049 |
| P2093 | author name string | Robin Emsley | |
| Liezl Koen | |||
| Piet P Oosthuizen | |||
| Martin Kidd | |||
| Dana J H Niehaus | |||
| H Jadri Turner | |||
| P433 | issue | 11 | |
| P921 | main subject | psychosis | Q170082 |
| P304 | page(s) | 1707-1712 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | The Journal of Clinical Psychiatry | Q7743563 |
| P1476 | title | Remission in first-episode psychosis: predictor variables and symptom improvement patterns | |
| P478 | volume | 67 |
| Q91966431 | A cross-sectional mixed methods protocol to describe correlates and explanations for a long duration of untreated psychosis among patients with first episode psychosis in Uganda |
| Q56523541 | Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study |
| Q38056641 | Antipsychotic treatment response in schizophrenia |
| Q51888816 | Association between financial strain, social network and five-year recovery from first episode psychosis. |
| Q35109168 | Clinical predictors of therapeutic response to antipsychotics in schizophrenia |
| Q48283069 | Does early antipsychotic response predict long-term treatment outcome? |
| Q43989313 | Early improvement on antipsychotic treatment as a predictor of subsequent response in schizophrenia: analyses from ziprasidone clinical studies |
| Q40881518 | Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial. |
| Q90606812 | Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate |
| Q46255754 | Evaluation of a multi-element treatment center for early psychosis in the United States |
| Q37516094 | Influencing Factors and Predictors of Early Response in Schizophrenia Patients Receiving the Paliperidone Extended-Release Tablets (Paliperidone ER) |
| Q34502693 | Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study |
| Q80587525 | Longitudinal research on bipolar disorders |
| Q41597228 | Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study |
| Q64100900 | Predictive Factors of Treatment Resistance in First Episode of Psychosis: A Systematic Review |
| Q46145982 | Rate and predictors of non-response to first-line antipsychotic treatment in first-episode schizophrenia |
| Q58567561 | Rate of and time to symptomatic remission in first-episode psychosis in Northern Malawi: A STROBE-compliant article |
| Q35237264 | Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later |
| Q36196626 | Remission status and cortical thickness in childhood-onset schizophrenia |
| Q92305975 | Symptom remission at 12-weeks strongly predicts long-term recovery from the first episode of psychosis |
| Q35635609 | Time to treatment response in first-episode schizophrenia: should acute treatment trials last several months? |
Search more.